PODD Live signals | Maximize Profits with Getagraph.com

BUY 378 min ago

@ $196.87

Issued: 1 Jul 2024 @ 13:44

Return: -0.36%

Previous signal: Jul 1 - 09:33

Previous signal: Sell

Return: -3.45 %

Live Chart Being Loaded With Signals

Commentary (1 Jul 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 0.01% compare to its pairs and should correct upwards.

Stats
Today's Volume	682 128
Average Volume	846 001
Market Cap	13.74B
EPS	$0.740 ( Q1 \| 2024-05-10 )
Next earnings date	( $0 ) 2024-08-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	58.91 (Sector) 42.63 (Industry) 0
ATR14	$13.45 (6.86%)

AEMD -9.77%

AFIB -12.68%

AHCO -2.70%

AHPI 0.00%

ALGN -1.16%

ANIK 2.05%

APEN 0.00%

APYX -2.99%

ARAY -3.30%

ATEC -4.50%

AXDX 0.00%

AXGN 6.49%

AXNX 0.10%

AZYO 2.05%

BBLG -2.44%

BIOL 7.80%

BJDX 0.87%

BMRA 0.07%

BRKR -2.32%

BSGM -0.06%

BWAY -3.46%

CERS -2.27%

CFMS 0.44%

CLPT -1.11%

CODX 0.80%

CSII 0.15%

CTKB 0.54%

CTSO -0.43%

CUTR -0.66%

CVRX -2.34%

DCTH -1.31%

DXCM -1.07%

DYNT -16.23%

EAR -4.10%

ECOR 0.00%

EDAP -4.04%

ESTA -4.62%

FONR 0.88%

HJLI -1.98%

HSDT -1.15%

HSKA 0.00%

HYPR 8.07%

IART -0.58%

ICAD -2.69%

ICCM -0.68%

IINN -11.59%

INGN -3.69%

INMD -2.03%

IRIX -3.24%

IRMD -1.14%

IRTC -1.11%

ISO 0.00%

ITMR 0.00%

KIDS -1.91%

LHDX 0.00%

LIVN -0.62%

LNSR -1.22%

LUCD -3.78%

LUNG -1.58%

MASS -7.38%

MDGS 10.28%

MOTS -16.81%

MOVE 5.78%

MSON 0.00%

NAOV -0.10%

NARI 4.24%

NMRD 33.33%

NNOX -2.59%

NPCE -3.17%

NTUS 0.00%

NURO -1.62%

NUVA -2.24%

NUWE -3.18%

NVCN 0.00%

NVNO -2.48%

OBLN -5.86%

OFIX -2.87%

OM -4.16%

PACB -12.41%

PAVM -6.26%

PETV -23.08%

PODD -2.79%

PRCT 1.28%

PROF 2.01%

QIPT -1.24%

QTRX -4.01%

RCEL -2.53%

RPID 3.05%

RSLS 3.86%

RWLK 6.07%

RXST -5.60%

SGHT -5.40%

SIBN -0.23%

SIEN -18.69%

SILK -0.33%

SINT -5.21%

SOLY 0.00%

SRDX -0.33%

SRGA 0.00%

SRTS -6.47%

SWAV 0.00%

TBIO 5.75%

TCMD -4.44%

TELA -4.47%

THMO -16.67%

TIVC -1.19%

TLIS -4.20%

TMCI -2.41%

TMDI 0.00%

TMDX -0.29%

TNDM -2.08%

TNON 18.05%

UFPT 9.56%

VERO -8.17%

VIVE 0.00%

VMD -2.29%

VRAY 0.00%

VREX -2.99%

VVOS 6.31%

XAIR 18.39%

XENT 0.00%

ZIMV -0.66%

Insider Trading

Date	Person	Action	Amount	type
2024-06-28	Field Mark N	Sell	141	Common Stock
2024-06-14	Field Mark N	Sell	1 500	Common Stock
2024-06-10	Scannell Timothy J	Sell	7 000	Common Stock
2024-06-10	Field Mark N	Sell	2 131	Common Stock
2024-06-04	Minogue Michael R	Buy	843	Common Stock

INSIDER POWER
16.75
Last 100 transactions
Buy: 203 215 \| Sell: 157 369

Correlation (AI algo v.1.1b): Undervalued: 0.01% $196.19 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: -0.08 (neutral)

Short: 0.12 (neutral)

Signal:(56) Neutral

Insulet Corp Correlation

10 Most Positive Correlations
IRDM	0.91
ACON	0.906
CYAN	0.902
AUPH	0.901
WISA	0.897
BIOL	0.893
SSRM	0.892
SABR	0.889
AMCX	0.889
TBLT	0.887

10 Most Negative Correlations
CDRO	-0.901
LPLA	-0.892
ARQT	-0.891
JSPR	-0.889
CLBT	-0.885
FREE	-0.881
TRVI	-0.879
EWJV	-0.878
NVDA	-0.872
AMAT	-0.871

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Insulet Corp Correlation - Currency/Commodity

-0.29
( neutral )

-0.44
( neutral )

0.00
( neutral )

-0.31
( neutral )

-0.44
( neutral )

-0.61
( weak negative )

Insulet Corp Financials

Annual	2023
Revenue:	$1.70B
Gross Profit:	$1.16B (68.35 %)
EPS:	$2.96

FY	2023
Revenue:	$1.70B
Gross Profit:	$1.16B (68.35 %)
EPS:	$2.96

FY	2022
Revenue:	$1.31B
Gross Profit:	$805.60M (61.72 %)
EPS:	$0.0663

FY	2021
Revenue:	$1.10B
Gross Profit:	$752.10M (68.45 %)
EPS:	$0.232

Financial Reports:

No articles found.

Insulet Corp Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.